• Markets
    • icon
  • Companies
AN1 · ASX

Anagenics Limited (ASX:AN1)

AU$0.008

 0.0 (0.0%)
ASX:Live
25/07/2024 12:00:00 AM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AN1 Overview

AN1 Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AN1

Website

N/A

Telephone

61.2.9221.6830

Address

Level 2 Suite 204 55 Clarence Street Sydney, New South Wales (NSW) 2000

Description

Anagenics Ltd. is a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the Anagenics Corporate and Consumer and Health segments. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.

AN1 Price Chart

Key Stats

Market Cap

AU$3.69M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.03

Trade Value (12mth)

AU$714.00

1 week

0%

1 month

14.29%

YTD

-57.89%

1 year

-50%

All time high

8.94

Key Fundamentals

EPS 3 yr Growth

-78.500%

EBITDA Margin

-17.10%

Operating Cashflow

-$2m

Free Cash Flow Return

-19.20%

ROIC

-18.80%

Interest Coverage

-48.90

Quick Ratio

2.20

Other Data

Shares on Issue (Fully Dilluted)

379m

HALO Sector

Staples

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AN1 Announcements

Latest Announcements

Date Announcements

24 July 24

Appendix 4C Cash Flow & Activities Report

×

Appendix 4C Cash Flow & Activities Report

24 July 24

Company Update License Partnership Announcement

×

Company Update License Partnership Announcement

28 June 24

Lapse of unlisted options

×

Lapse of unlisted options

13 June 24

Change of Company Secretary

×

Change of Company Secretary

24 May 24

Pause in Trading

×

Pause in Trading

24 May 24

Trading Halt

×

Trading Halt

24 May 24

Midkine Antibody Licensing Deal

×

Midkine Antibody Licensing Deal

20 May 24

Response to Appendix 3Y Query

×

Response to Appendix 3Y Query

13 May 24

Change of Director's Interest Notices

×

Change of Director's Interest Notices

29 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

19 April 24

Change in substantial holding - HNG

×

Change in substantial holding - HNG

17 April 24

Application for quotation of securities - AN1

×

Application for quotation of securities - AN1

17 April 24

Cleansing Notice

×

Cleansing Notice

17 April 24

Notification regarding unquoted securities - AN1

×

Notification regarding unquoted securities - AN1

11 April 24

Results of Meeting

×

Results of Meeting

13 March 24

Change of Director's Interest Notice - Beard

×

Change of Director's Interest Notice - Beard

13 March 24

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

11 March 24

Change of Director's Interest Notice - Beard

×

Change of Director's Interest Notice - Beard

08 March 24

Organisational Changes

×

Organisational Changes

27 February 24

Appendix 4D and Half Year Report

×

Appendix 4D and Half Year Report

27 February 24

H1 FY24 Results and Corporate Update

×

H1 FY24 Results and Corporate Update

20 February 24

Change in substantial holding - HNG

×

Change in substantial holding - HNG

15 February 24

Application for quotation of securities - AN1

×

Application for quotation of securities - AN1

15 February 24

Cleansing Notice

×

Cleansing Notice

07 February 24

Completion of Placement

×

Completion of Placement

07 February 24

Investor Presentation

×

Investor Presentation

AN1 Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.9 37.1 42.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 45.9 13.5 69.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -49.5 -53.7 -40.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.06 0.04 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -19.7 -54.6 -31.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 143 211 266 Lock Lock Lock
Basic m Lock Lock Lock Lock 143 211 266 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 6 9 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -20.8 58.8 -1.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 6 9 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 5 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.6 36.8 -20.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 63.7 54.8 44.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 36 45 56 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.6 -71.2 51.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -31.9 -34.4 -17.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -2 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.5 -59.1 47.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -39.7 -39.8 -21.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -4 -4 -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.2 6.8 26.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -67.3 -39.5 -29.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -1 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 0 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.6 38.3 29.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.7 -0.3 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 3 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 13 13 11 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 -2 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 5 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 10 8 9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 9 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.2 -18.9 2.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -29.5 -28.2 -24.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -19.5 -33.5 -19.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -33.7 -35.7 -18.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -36.9 -25.0 -19.2 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -33.9 -45.5 -48.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.9 0.5 1.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -50.7 -18.4 -21.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.9 2.4 3.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.6 1.2 2.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 59.6 37.5 41.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -217.7 -69.7 -103.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.2 6.8 9.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.8 1.2 1.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 1.8 2.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.7 5.4 7.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.7 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.7 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -75.7 -44.9 -24.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -33.1 -32.1 -19.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -29.5 -28.2 -24.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.6 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 445.7 306.3 246.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 115.0 53.7 40.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 560.7 360.0 287.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 135.3 35.6 74.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 425.4 324.3 212.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AN1 Shortsell

Frequently Asked Questions

The current share price of Anagenics Limited (AN1:ASX) is AU$0.008.
The 52-week high share price for Anagenics Limited (AN1:ASX) is AU$0.03.
The 52-week low share price for Anagenics Limited (AN1:ASX)? is AU$0.01.
Anagenics Limited (AN1:ASX) does not pay a dividend.
Anagenics Limited (AN1:ASX) does not pay a dividend.
Anagenics Limited (AN1:ASX) has a franking level of 0.0%.
Anagenics Limited (AN1:ASX) is classified in the Staples.
The current P/E ratio for Anagenics Limited (AN1:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.